Fermentation is a biochemical process that involves the conversion of sugars into acids, gases, or alcohol using microorganisms such as bacteria, yeast, or fungi. This natural process has been harnessed for thousands of years in various industries, including food and beverage, pharmaceuticals, and biofuels. The development of fermentation processes has evolved significantly, driven by...

Introduction PEGylation, the process of attaching polyethylene glycol (PEG) chains to therapeutic molecules, has become a cornerstone in pharmaceutical development. This technique improves the pharmacokinetic and pharmacodynamic properties of drugs, enhancing their stability, solubility, and circulation time while reducing immunogenicity. Since its first FDA-approved application in 1990 with...

Fluorinated building blocks are specialized chemical compounds that contain fluorine atoms and serve as key intermediates in the synthesis of pharmaceuticals, agrochemicals, and advanced materials. Due to the unique properties of fluorine—such as high electronegativity, small atomic size, and strong carbon-fluorine bonds—these building blocks enhance the stability,...

Polymer additives play a critical role in the processing and performance of polymer materials. These additives are substances included in the polymer matrix during manufacturing to modify the material's physical properties, improve processing qualities, or enhance performance characteristics. This article explores the types, functions, and significance of polymer additives in various...

PEGylation of nanoparticles, the process of attaching polyethylene glycol (PEG) chains to nanoparticles, has transformed the landscape of drug and gene delivery. Its multifaceted role can be encapsulated through various mechanisms that enhance the efficacy and safety of therapeutic agents while also leading to potential challenges that require strategic optimizations.   Core Functions of...

Epstein-Barr Virus (EBV), a member of the herpesvirus family, is one of the most common viruses in humans, infecting more than 90% of the global population at some point in their lives. While many individuals remain asymptomatic or experience mild symptoms, EBV can lead to significant health issues, including infectious mononucleosis, certain cancers (such as Hodgkin lymphoma and Nasopharyngeal...